← Leaderboards
Udo Hoffmann
Massachusetts General Hospital
$17,171,978
Attributed
$22,168,632
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2006–20$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$22,168,632 · 9
By mechanism
U01$10,067,481 · 2
R01$6,480,009 · 3
T32$2,329,440 · 1
R33$1,437,929 · 1
K24$1,123,870 · 1
R61$729,903 · 1
Top collaborators
- Heather Jane Ribaudo5 shared
- Priscilla Y. Hsue3 shared
- Ahmed A Tawakol3 shared
- Pamela Susan Douglas1 shared
- Svati H. Shah1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jing Zhou$20,912,829
- Steven Kyle Grinspoon$75,757,679
- Guillermo J. Tearney$42,608,505
- Ahmed A Tawakol$9,912,063
- Brett E Bouma$16,028,207
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacImageRandomizedCoronaryChest PainCoronary ArteriosclerosisEventUnited States National Institutes Of HealthIndexingDiagnosticBaseAcuteAngiographyDiagnostic TestsHospitalizationResearch PersonnelProgramsRisk FactorsGrantFundingLeadershipCost EffectivenessMyocardial IschemiaCost
Grant awards (37)
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)$721,297
R33 · FY2020 · HL
Cardiovascular Imaging in Ischemic Heart Disease$120,852
K24 · FY2020 · HL · contact PI
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,485,906
R01 · FY2019 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)$716,632
R33 · FY2019 · HL
Cardiovascular Imaging in Ischemic Heart Disease$120,852
K24 · FY2019 · HL · contact PI
REPRIEVE - DCC$926,776
U01 · FY2018 · HL · contact PI
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)$729,903
R61 · FY2018 · HL
Cardiac MR and CT Research$297,033
T32 · FY2018 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$120,852
K24 · FY2018 · HL · contact PI
REPRIEVE - DCC$906,151
U01 · FY2017 · HL · contact PI
Cardiac MR and CT Research$380,168
T32 · FY2017 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$121,969
K24 · FY2017 · HL · contact PI
REPRIEVE - DCC$957,177
U01 · FY2016 · HL · contact PI
Cardiac MR and CT Research$257,488
T32 · FY2016 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$127,869
K24 · FY2016 · HL · contact PI
REPRIEVE - DCC$972,448
U01 · FY2015 · HL · contact PI
Cardiac MR and CT Research$362,262
T32 · FY2015 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$127,869
K24 · FY2015 · HL · contact PI
REPRIEVE - DCC$1,359,105
U01 · FY2014 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$127,869
K24 · FY2014 · HL · contact PI
PROMISE Trial: Dx Core$43,426
R01 · FY2014 · HL · contact PI
Cardiac MR and CT Research$359,410
T32 · FY2013 · HL · contact PI
ROMICAT II - CCC - Lead Application$258,476
U01 · FY2013 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$127,869
K24 · FY2013 · HL · contact PI
PROMISE Trial: Dx Core$42,058
R01 · FY2013 · HL · contact PI
ROMICAT II - CCC - Lead Application$1,045,138
U01 · FY2012 · HL · contact PI
PROMISE Trial: Dx Core$595,030
R01 · FY2012 · HL · contact PI
Cardiac MR and CT Research$340,962
T32 · FY2012 · HL · contact PI
Cardiovascular Imaging in Ischemic Heart Disease$127,869
K24 · FY2012 · HL · contact PI
Cardiac MR and CT Research$332,117
T32 · FY2011 · HL · contact PI
ROMICAT II - CCC - Lead Application$1,913,403
U01 · FY2010 · HL · contact PI
PROMISE Trial: Dx Core$1,104,840
R01 · FY2010 · HL · contact PI
ROMICAT II - CCC - Lead Application$1,728,807
U01 · FY2009 · HL · contact PI
PROMISE Trial: Dx Core$1,697,082
R01 · FY2009 · HL · contact PI
Cardiac MDCT for Early Triage of Patients with ACS$522,822
R01 · FY2008 · HL · contact PI
Cardiac MDCT for Early Triage of Patients with ACS$526,873
R01 · FY2007 · HL · contact PI
Cardiac MDCT for Early Triage of Patients with ACS$461,972
R01 · FY2006 · HL · contact PI